ArticleDrugs - real world outcomes2021

Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy.

Leorah Freeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.